Literature DB >> 26033611

Functionally Active Gap Junctions between Connexin 43-Positive Mesenchymal Stem Cells and Glioma Cells.

A N Gabashvili1, V P Baklaushev, N F Grinenko, A B Levinskii, P A Mel'nikov, S A Cherepanov, V P Chekhonin.   

Abstract

The formation of functional gap junctions between mesenchymal stem cells and cells of low-grade rat glioma C6 cells was studied in in vitro experiments. Immunocytochemical analysis with antibodies to connexin 43 extracellular loop 2 showed that mesenchymal stem cells as well as C6 glioma cells express the main astroglial gap junction protein connexin 43. Analysis of migration activity showed that mesenchymal stem cells actively migrate towards C6 glioma cells. During co-culturing, mesenchymal stem cells and glioma C6 form functionally active gap junctions mediating the transport of cytoplasmic dye from glioma cells to mesenchymal stem cells in the opposite direction. Fluorometry showed that the intensity of transport of low-molecular substances through heterologous gap junctions between mesenchymal stem cells and glioma cells is similar to that through homologous gap junctions between glioma cells. This phenomenon can be used for the development of new methods of cell therapy of high-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26033611     DOI: 10.1007/s10517-015-2916-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Connexin43 is Dispensable for Early Stage Human Mesenchymal Stem Cell Adipogenic Differentiation But is Protective against Cell Senescence.

Authors:  Qing Shao; Jessica L Esseltine; Tao Huang; Nicole Novielli-Kuntz; Jamie E Ching; Jacinda Sampson; Dale W Laird
Journal:  Biomolecules       Date:  2019-09-11

Review 2.  Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).

Authors:  Igor Bryukhovetskiy; Arina Ponomarenko; Irina Lyakhova; Sergey Zaitsev; Yulia Zayats; Maria Korneyko; Marina Eliseikina; Polina Mischenko; Valerie Shevchenko; Hari Shanker Sharma; Aruna Sharma; Yuri Khotimchenko
Journal:  Int J Mol Med       Date:  2018-05-10       Impact factor: 4.101

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.